ACE2 in Viral Infections and Neurodegeneration: The Dual Role of a Peptide Enzyme

Review of ACE2's dual role as both SARS-CoV-2 entry receptor and neuroprotective enzyme explores how viral infections and neurodegeneration intersect through this peptide-processing enzyme.

Amelimojarad, Melika et al.·Journal of neurovirology·2025·Moderate EvidenceReview
RPEP-09922ReviewModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
N=not applicable
Participants
Review covering ACE2 biology in neurological health and SARS-CoV-2 infection

What This Study Found

Review of ACE2's dual role as both SARS-CoV-2 entry receptor and neuroprotective enzyme explores how viral infections and neurodegeneration intersect through this peptide-processing enzyme.

Key Numbers

Review covers ACE2's roles in metabolizing angiotensin II and apelin-13, and the neurological consequences of SARS-CoV-2 spike protein binding.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide therapeutic knowledge.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Comparison to evidence?
  • ?Next research?

Trust & Context

Key Stat:
Key finding Review of ACE2's dual role as both SARS-CoV-2 entry receptor and neuroprotective enzyme explores how
Evidence Grade:
Based on study design.
Study Age:
Published in 2025.
Original Title:
The dual role of ACE2 in viral infections and neurodegeneration: mechanisms and therapeutic opportunities.
Published In:
Journal of neurovirology, 31(5), 397-406 (2025)
Database ID:
RPEP-09922

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does this mean?

Review of ACE2's dual role as both SARS-CoV-2 entry receptor and neuroprotective enzyme explores how viral infections and neurodegeneration intersect through this peptide-processing enzyme.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09922·https://rethinkpeptides.com/research/RPEP-09922

APA

Amelimojarad, Melika; Amelimojarad, Mandana. (2025). The dual role of ACE2 in viral infections and neurodegeneration: mechanisms and therapeutic opportunities.. Journal of neurovirology, 31(5), 397-406. https://doi.org/10.1007/s13365-025-01282-7

MLA

Amelimojarad, Melika, et al. "The dual role of ACE2 in viral infections and neurodegeneration: mechanisms and therapeutic opportunities.." Journal of neurovirology, 2025. https://doi.org/10.1007/s13365-025-01282-7

RethinkPeptides

RethinkPeptides Research Database. "The dual role of ACE2 in viral infections and neurodegenerat..." RPEP-09922. Retrieved from https://rethinkpeptides.com/research/amelimojarad-2025-the-dual-role-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.